CLINICAL OUTCOMES ASSOCIATED WITH SODIUM ZIRCONIUM CYCLOSILICATE FOR TREATING HYPERKALAEMIA IN PATIENTS RECEIVING HAEMODIALYSIS

被引:0
|
作者
Ferraro, P. M. [1 ]
Booth, D. [2 ]
Silvanto, J. [2 ]
McEwan, P. [2 ]
Rao, N. [3 ]
机构
[1] Univ Cattolica Sacro Cuore, Dipartimento Univ Med Chirurg Traslazional, Rome, Italy
[2] Hlth Econ & Outcomes Res Ltd, Cardiff, Wales
[3] AstraZeneca, Cambridge, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
CO35
引用
收藏
页码:S20 / S20
页数:1
相关论文
共 50 条
  • [11] Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate
    Rosano, Giuseppe M. C.
    Spoletini, Ilaria
    Agewall, Stefan
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0A) : A28 - A33
  • [12] Comparison of sodium zirconium cyclosilicate and sodium polystyrene sulfonate in the treatment of acute hyperkalaemia
    Thai, Tommy
    Hong, Lisa
    Hauschild, Christopher
    Iso, Tomona
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
  • [13] Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden
    Kun Kim
    Josefine Fagerström
    Gengshi Chen
    Zoya Lagunova
    Hans Furuland
    Phil McEwan
    BMC Nephrology, 23
  • [14] Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden
    Kim, Kun
    Fagerstrom, Josefine
    Chen, Gengshi
    Lagunova, Zoya
    Furuland, Hans
    McEwan, Phil
    BMC NEPHROLOGY, 2022, 23 (01)
  • [15] An evaluation of sodium zirconium cyclosilicate: a new treatment option for hyperkalaemia in China
    Lu, Yuan
    Liu, Bi-Cheng
    Liu, Hong
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (03) : 301 - 308
  • [16] EVALUATION OF THE EFFECT OF A POTASSIUM BINDER ON ARRHYTHMIA-RELATED CARDIOVASCULAR OUTCOMES IN PATIENTS ON CHRONIC HAEMODIALYSIS WITH RECURRENT HYPERKALAEMIA: DESIGN AND RATIONALE FOR THE SODIUM ZIRCONIUM CYCLOSILICATE DIALIZE-OUTCOMES STUDY
    Fishbane, Steven
    Jadoul, Michel
    Dember, Laura M.
    Kovesdy, Csaba
    Sabir, Ian
    Al-Shurbaji, Ayman
    Thoren, Fredrik
    Katona, Brian G.
    Guzman, Nicolas
    Xu, John
    Herzog, Charles A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [17] Mortality and hyperkalaemia-associated hospitalisation in patients with chronic kidney disease: comparison of sodium zirconium cyclosilicate and sodium/calcium polystyrene sulfonate
    Onogi, Chikao
    Watanabe, Yu
    Tanaka, Akihito
    Furuhashi, Kazuhiro
    Maruyama, Shoichi
    CLINICAL KIDNEY JOURNAL, 2024, 17 (02)
  • [18] Sodium zirconium cyclosilicate (Lokelma®) for treating lithium toxicity
    Burtle, Addie
    Mullins, Michael E.
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2023, 63 : 169 - 170
  • [19] Sodium Zirconium Cyclosilicate: A Review in Hyperkalaemia (vol 78, pg 1605, 2018)
    Hoy, Sheridan M.
    DRUGS, 2019, 79 (05) : 591 - 591
  • [20] Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode
    Arroyo, David
    Pollack, Charles V., Jr.
    Kanda, Eiichiro
    Sanchez Lazaro, Ignacio Jose
    Lesen, Eva
    Franzen, Stefan
    Gray, Christen M.
    Murohara, Toyoaki
    Rastogi, Anjay
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I115 - I115